You are here: Home Faculty Professors Korinthenberg

Korinthenberg

Prof. Dr.
Rudolf Korinthenberg

Department of Neuropediatrics and Muscle Disorders
Medical Director
Phone: 0049-761-270-43150

www.uniklinik-freiburg.de/paed-neuro

CV

  • 1967-1973 Medical studies, University of Münster
  • 1976-1986 senior house officer and registrar, Department of Pediatrics, University of Münster
  • 1985 Habilitation in Pediatrics
  • 1986-1990 Consultant and Professor (C2), Medical Faculty Mannheim, University of Heidelberg
  • Since 1990 Professor (C3) and Medical Director, Department of Neuropediatrics and Muscular diseases, Medical Center – University of Freiburg

Focus of research

  • Treatment of epilepsy in childhood
  • Guillain-Barré syndrome and CIDP in childhood
  • Clinical trials in Duchenne muscular dystrophy and spinal muscular atrophy

Selected publications

  • Kirschner J, Schorling D, Hauschke D, Rensing-Zimmermann C, Wein U, Grieben U, Schottmann G, Schara U, Konrad K, Müller-Felber W, Thiele S, Wilichowski E, Hobbiebrunken E, Stettner GM, Korinthenberg R. Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot study. Neuromuscul Disord. 2014; 24(2):134-42.
  • Korinthenberg R. Acute polyradiculoneuritis: Guillain-Barré syndrome. Handb Clin Neurol. 2013; 112:1157-62.
  • Kirschner J, Schessl J, Schara U, Reitter B, Stettner GM, Hobbiebrunken E, Wilichowski E, Bernert G, Weiss S, Stehling F, Wiegand G, Müller-Felber W, Thiele S, Grieben U, von der Hagen M, Lütschg J, Schmoor C, Ihorst G, Korinthenberg R. Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial. Lancet Neurol. 2010; 9(11):1053-9.
  • Korinthenberg R, Neuburger D, Trippel M, Ostertag C, Nikkhah G. Long-term results of brachytherapy with temporary iodine-125 seeds in children with low-grade gliomas. Int J Radiat Oncol Biol Phys. 2011; 79(4):1131-8.
  • Korinthenberg R, Schessl J, Kirschner J, Mönting JS. Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial. Pediatrics. 2005; 116(1):8-14.